SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Vivoryon Therapeutics to Report Q3 2026 Results November 5

Vivoryon Therapeutics said it will report Q3 2026 financial results on November 5, 2026.

Related stories